Orpha Labs AG Initiates Compassionate Use Program for ORL-101 ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BAAR, Switzerland, Feb. 8, 2021 /PRNewswire-AsiaNet/-- -- First Patient to Receive ORL-101 in Israel This WeekOrpha Labs AG today announced its compassionate use program to make ORL-101 available to physicians providing care for Leukocyte Adhesion Deficiency Type II (LAD-II) patients. ORL-101 is a...
Authors: LATEST ASIANET NEWS RELEASES